rs1042522
|
|
|
0.080 |
GeneticVariation |
BEFREE |
The aim of the study was to determine an association of TP53 codon 72 (Arg72Pro, G>C transversion, rs1042522) and MDM2 SNP309 (T>G change, rs2279744) polymorphisms in endometrial cancer (EC) of postmenopausal women, regarding grading and staging of EC.
|
25316267 |
2014 |
rs1131691014
|
|
|
0.080 |
GeneticVariation |
BEFREE |
The aim of the study was to determine an association of TP53 codon 72 (Arg72Pro, G>C transversion, rs1042522) and MDM2 SNP309 (T>G change, rs2279744) polymorphisms in endometrial cancer (EC) of postmenopausal women, regarding grading and staging of EC.
|
25316267 |
2014 |
rs878854066
|
|
|
0.080 |
GeneticVariation |
BEFREE |
The aim of the study was to determine an association of TP53 codon 72 (Arg72Pro, G>C transversion, rs1042522) and MDM2 SNP309 (T>G change, rs2279744) polymorphisms in endometrial cancer (EC) of postmenopausal women, regarding grading and staging of EC.
|
25316267 |
2014 |
rs1042522
|
|
|
0.080 |
GeneticVariation |
BEFREE |
Association of MDM2 SNP309 and TP53 Arg72Pro polymorphisms with risk of endometrial cancer.
|
23624782 |
2013 |
rs1042522
|
|
|
0.080 |
GeneticVariation |
BEFREE |
The aim of this study was to detect TP53 Arg72Pro polymorphism in postmenopausal patients with endometrial cancer (EC), to evaluate the risk of EC connected with it, as well to check for possible relationships with staging, grading and some risk factors of this neoplasm.
|
24379271 |
2013 |
rs1042522
|
|
|
0.080 |
GeneticVariation |
BEFREE |
Genotype misclassification in genetic association studies of the rs1042522 TP53 (Arg72Pro) polymorphism: a systematic review of studies of breast, lung, colorectal, ovarian, and endometrial cancer.
|
23729685 |
2013 |
rs1131691014
|
|
|
0.080 |
GeneticVariation |
BEFREE |
Genotype misclassification in genetic association studies of the rs1042522 TP53 (Arg72Pro) polymorphism: a systematic review of studies of breast, lung, colorectal, ovarian, and endometrial cancer.
|
23729685 |
2013 |
rs1131691014
|
|
|
0.080 |
GeneticVariation |
BEFREE |
Association of MDM2 SNP309 and TP53 Arg72Pro polymorphisms with risk of endometrial cancer.
|
23624782 |
2013 |
rs1131691014
|
|
|
0.080 |
GeneticVariation |
BEFREE |
The aim of this study was to detect TP53 Arg72Pro polymorphism in postmenopausal patients with endometrial cancer (EC), to evaluate the risk of EC connected with it, as well to check for possible relationships with staging, grading and some risk factors of this neoplasm.
|
24379271 |
2013 |
rs878854066
|
|
|
0.080 |
GeneticVariation |
BEFREE |
Association of MDM2 SNP309 and TP53 Arg72Pro polymorphisms with risk of endometrial cancer.
|
23624782 |
2013 |
rs878854066
|
|
|
0.080 |
GeneticVariation |
BEFREE |
Genotype misclassification in genetic association studies of the rs1042522 TP53 (Arg72Pro) polymorphism: a systematic review of studies of breast, lung, colorectal, ovarian, and endometrial cancer.
|
23729685 |
2013 |
rs878854066
|
|
|
0.080 |
GeneticVariation |
BEFREE |
The aim of this study was to detect TP53 Arg72Pro polymorphism in postmenopausal patients with endometrial cancer (EC), to evaluate the risk of EC connected with it, as well to check for possible relationships with staging, grading and some risk factors of this neoplasm.
|
24379271 |
2013 |
rs1042522
|
|
|
0.080 |
GeneticVariation |
BEFREE |
It has been suggested that the p53 tumor suppressor gene Arg72Pro polymorphism is associated with endometrial cancer.
|
22277327 |
2012 |
rs1131691014
|
|
|
0.080 |
GeneticVariation |
BEFREE |
It has been suggested that the p53 tumor suppressor gene Arg72Pro polymorphism is associated with endometrial cancer.
|
22277327 |
2012 |
rs878854066
|
|
|
0.080 |
GeneticVariation |
BEFREE |
It has been suggested that the p53 tumor suppressor gene Arg72Pro polymorphism is associated with endometrial cancer.
|
22277327 |
2012 |
rs1042522
|
|
|
0.080 |
GeneticVariation |
BEFREE |
In conclusion, we did not observe any evidence for a role of TP53 Arg72Pro polymorphism in endometrial cancer.
|
20552298 |
2011 |
rs1131691014
|
|
|
0.080 |
GeneticVariation |
BEFREE |
In conclusion, we did not observe any evidence for a role of TP53 Arg72Pro polymorphism in endometrial cancer.
|
20552298 |
2011 |
rs878854066
|
|
|
0.080 |
GeneticVariation |
BEFREE |
In conclusion, we did not observe any evidence for a role of TP53 Arg72Pro polymorphism in endometrial cancer.
|
20552298 |
2011 |
rs1042522
|
|
|
0.080 |
GeneticVariation |
BEFREE |
Our data did not demonstrate any significant difference in the prevalence of the p53 Arg72Pro genotype between patients and controls, providing evidence that this polymorphism is only weakly associated with the risk of endometrial cancer and prognostic factors in Caucasian women.
|
19209008 |
2009 |
rs1131691014
|
|
|
0.080 |
GeneticVariation |
BEFREE |
Our data did not demonstrate any significant difference in the prevalence of the p53 Arg72Pro genotype between patients and controls, providing evidence that this polymorphism is only weakly associated with the risk of endometrial cancer and prognostic factors in Caucasian women.
|
19209008 |
2009 |
rs878854066
|
|
|
0.080 |
GeneticVariation |
BEFREE |
Our data did not demonstrate any significant difference in the prevalence of the p53 Arg72Pro genotype between patients and controls, providing evidence that this polymorphism is only weakly associated with the risk of endometrial cancer and prognostic factors in Caucasian women.
|
19209008 |
2009 |
rs1042522
|
|
|
0.080 |
GeneticVariation |
BEFREE |
Association of p73 G4C14-to-A4T14 polymorphism at exon 2 and p53 Arg72Pro polymorphism with the risk of endometrial cancer in Japanese subjects.
|
15723718 |
2005 |
rs1131691014
|
|
|
0.080 |
GeneticVariation |
BEFREE |
Association of p73 G4C14-to-A4T14 polymorphism at exon 2 and p53 Arg72Pro polymorphism with the risk of endometrial cancer in Japanese subjects.
|
15723718 |
2005 |
rs878854066
|
|
|
0.080 |
GeneticVariation |
BEFREE |
Association of p73 G4C14-to-A4T14 polymorphism at exon 2 and p53 Arg72Pro polymorphism with the risk of endometrial cancer in Japanese subjects.
|
15723718 |
2005 |
rs1056836
|
|
|
0.050 |
GeneticVariation |
BEFREE |
In summary, this meta-analysis suggests that Leu432Val polymorphism is associated with ovarian cancer, lung cancer, and endome</span>trial cancer risk; Asn453Ser and Arg48Gly polymorphisms are associated with endometrial cancer risk among Caucasians, Ala119Ser polymorphism is associated with prostate cancer risk, and Ala119Ser polymorphism is associated with breast cancer risk in Caucasians.
|
25475389 |
2015 |